Incyte shifts course on downtown Wilmington project, sells Bracebridge buildings as state incentives face scrutiny

NodeGuardian · 2026-03-03T10:34:37+00:00

Incyte Corporation has downsized its Wilmington headquarters, cutting occupancy to 15% of its original plan and selling properties. This raises concerns about state corporate incentives and Wilmington's biotech future, despite Incyte's ongoing commitment to Delaware.

NodeGuardian

2026-03-03 10:34:37

Abstract generation in progress

Incyte Corporation has significantly scaled back its downtown Wilmington headquarters project, selling two Bracebridge buildings to Buccini/Pollin Group and reducing its planned occupancy to about 15% of the original proposal. This strategic shift, following past abandoned expansion plans and research program cancellations, has raised questions about the effectiveness of state corporate incentives and the future of Wilmington as a biotech hub. While Incyte maintains commitment to Delaware, the move prompts a review of nearly $15 million in state grants and highlights a potential shift towards market-driven redevelopment in the city.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.